(Q46419373)

22 December 2017

title

Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats (English)

1 reference

22 December 2017

1 reference

Hanumantha R Ancha

1

1 reference

22 December 2017

Ravi R Kurella

2

1 reference

22 December 2017

Christine C McKimmey

3

1 reference

22 December 2017

Stanley Lightfoot

4

1 reference

22 December 2017

Richard F Harty

5

1 reference

22 December 2017

publication date

21 August 2008

1 reference

22 December 2017

Digestive Diseases and Sciences

published in

1 reference

22 December 2017

volume

54

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

758-766

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s10620-008-0438-0

exact match

0 references

cites work

Replenishment of glutathione levels improves mucosal function in experimental acute colitis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-008-0438-0

Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-008-0438-0

Clinical implications of oxidative stress and antioxidant therapy.

21 January 2018

1 reference

12 December 2020

The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy

1 reference

12 December 2020

Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?

1 reference

12 December 2020

Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine

1 reference

12 December 2020

Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites

1 reference

12 December 2020

Inflammatory Bowel Disease

1 reference

12 December 2020

Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.

1 reference

12 December 2020

Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants

1 reference

12 December 2020

Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice.

1 reference

12 December 2020

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

1 reference

12 December 2020

Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation

1 reference

12 December 2020

The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis

1 reference

12 December 2020

Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity

1 reference

12 December 2020

Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease

1 reference

12 December 2020

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

1 reference

12 December 2020

Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats

1 reference

12 December 2020

Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis

1 reference

12 December 2020

Antioxidant therapy with N-acetylcysteine plus mesalamine accelerates mucosal healing in a rodent model of colitis

1 reference

12 December 2020

Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis

1 reference

12 December 2020

Non-stop progress in inflammatory bowel disease: new players, new understanding, new therapies

1 reference

12 December 2020

Role of reactive oxygen metabolites in experimental colitis

1 reference

12 December 2020

Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid

1 reference

12 December 2020

Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease

1 reference

12 December 2020

Prostaglandins and epithelial response to injury

1 reference

12 December 2020

alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice

1 reference

12 December 2020

Interleukin-17 and lipopolysaccharides synergistically induce cyclooxygenase-2 expression in human intestinal myofibroblasts.

1 reference

12 December 2020

Progress in understanding the mechanisms of action of 5-aminosalicylic acid

1 reference

12 December 2020

Effects and mechanism of the selective COX-2 inhibitor, celecoxib, on rat colitis induced by trinitrobenzene sulfonic acid

1 reference

12 December 2020

Using COX-2 inhibitors in IBD: anti-inflammatories inflame a controversy

1 reference

12 December 2020

A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease.

1 reference

12 December 2020

Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.

1 reference

12 December 2020

Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide

1 reference

12 December 2020

Oxidants and free radicals in inflammatory bowel disease

1 reference

12 December 2020

10.1007/S10620-008-0438-0

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017